Avanos eliminates Chief Commercial Officer and General Counsel positions; two executives to leave Dec 1

AVANOS MEDICAL, INC.

Kerr Holbrook (CCO) and Mojirade James (General Counsel & Secretary) terminated effective Dec 1, 2025 due to position elimination in restructuring.
Severance: Holbrook ~$1.54M, James ~$1.43M, plus 12 months COBRA premium coverage.
Unvested equity: time-based RSUs vest pro rata; performance-based RSUs vest at end of period; stock options exercisable for 5 years.
Prorated 2025 bonuses at target approved for both executives.
Payments conditional on separation agreement, general release, and continued compliance with confidentiality/non-solicitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.